Immunotherapy such as PD-1 inhibitors could suppress tumor through various mechanisms, including enhancing anti-tumor immune responses, synergistic effects of combination therapies, modulating the tumor microenvironment, and impacting tumor metastasis (28). The gene discussed is PDCD1; the disease is neoplasm.